Browse Definitions :
Definition

pharmacovigilance

Pharmacovigilance is the use of scientific methods to identify, track, record and analyze over time the effects of various pharmaceutical goods in order to ensure drug quality and safety. Pharmacovigilance pertains to almost every part of the drug lifecycle, ranging from preclinical development to post-market surveillance. Pharmacovigilance programs often deal with counterfeit drugs because counterfeiting can hamper the performance of otherwise safe pharmaceuticals.

The aim of pharmacovigilance is to find possible risks and adverse effects, analyze medical information to track effects, and inform health-care professionals and the public of this information. Other goals of pharmacovigilance include the early detection of safety problems that are not revealed during clinical trials, the identification and quantification of risks, and the improvement of patient care as well as safety in relation to the use of pharmaceutical drugs.

A key aspect of pharmacovigilance is identifying which side effects are worth the risk to patients, versus how effective they are at treating a disease. For instance, chemotherapy’s serious side effects – weighed against life-threatening cancer – may be considered acceptable, given the potential to cure a patient. Yet if a drug for curing a headache caused similar side effects, the risk to the patient would outweigh the benefits.

Pharmacovigilance is a crucial function within life science companies. Businesses that develop, manufacture and commercialize drugs must adhere to strict regulations, many of which focus on patient safety and well-being – and are at the heart of pharmacovigilance.

A strong pharmacovigilance strategy requires expertise in medicine, regulatory requirements and technology. It involves strong processes, case study report capture and processing, literature screening, signal detection and assessment, risk management, periodic safety writing, regulatory expedited reporting and safety databases. 

Organizations that have pharmacovigilance programs designed to monitor drug use statistics; identify risks and adverse effects; and educate the medical, scientific and lay communities regarding drug safety include the World Health Organization, the International Society of Pharmacovigilance, the U.S. Food and Drug Administration (FDA), and the U.K.’s Medicines & Healthcare Products Regulatory Agency.

This was last updated in November 2017

SearchCompliance

SearchSecurity

  • cyber attack

    A cyber attack is any attempt to gain unauthorized access to a computer, computing system or computer network with the intent to ...

  • backdoor (computing)

    A backdoor is a means to access a computer system or encrypted data that bypasses the system's customary security mechanisms.

  • post-quantum cryptography

    Post-quantum cryptography, also called quantum encryption, is the development of cryptographic systems for classical computers ...

SearchHealthIT

SearchDisasterRecovery

  • risk mitigation

    Risk mitigation is a strategy to prepare for and lessen the effects of threats faced by a business.

  • call tree

    A call tree is a layered hierarchical communication model that is used to notify specific individuals of an event and coordinate ...

  • Disaster Recovery as a Service (DRaaS)

    Disaster recovery as a service (DRaaS) is the replication and hosting of physical or virtual servers by a third party to provide ...

SearchStorage

  • cloud SLA (cloud service-level agreement)

    A cloud SLA (cloud service-level agreement) is an agreement between a cloud service provider and a customer that ensures a ...

  • NOR flash memory

    NOR flash memory is one of two types of non-volatile storage technologies.

  • RAM (Random Access Memory)

    RAM (Random Access Memory) is the hardware in a computing device where the operating system (OS), application programs and data ...

Close